Breast cancer histopathology, classification and clinical management: Current perspectives

Breast cancer (BC) manifests as a diverse group of malignancies and presents as a wide array of tumors with distinct morphological, biological and clinical characteristics. Molecular classification of BC serves as the basis for current precision-oriented therapeutic strategies. Upcoming therapeutic strategies will emphasize personalized medicine and tailoring treatments according to each patient's specific needs. These approaches will involve modulating the therapy intensity based on the biological characteristics of tumours and early predictive indicators, allowing for more precise and adaptable care in oncology. Additionally, there remains an unfulfilled requirement for the creation of new medications to treat breast cancer in its early stages, as well as in advanced cases. This review article presents an extensive examination of breast cancer, delving into its prevalence, contributing factors, molecular and cellular features and therapeutic interventions.

Authors

Institutions

Publication Details

Journal
Bioinformation
Published
2024-12-31
DOI
https://doi.org/10.6026/9732063002002069
Citations
3
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
0.85
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Breast cancer histopathology, classification and clinical management: Current perspectives

Ravindra Waykar, Srinivasakumar Kumarapillai
3 citations
Bioinformation
HER2/EGFR in Cancer Research
0.85
article

Breast cancer histopathology, classification and clinical management: Current perspectives

Ravindra Waykar, Srinivasakumar Kumarapillai
article en
3 citations

Abstract

Breast cancer (BC) manifests as a diverse group of malignancies and presents as a wide array of tumors with distinct morphological, biological and clinical characteristics. Molecular classification of BC serves as the basis for current precision-oriented therapeutic strategies. Upcoming therapeutic strategies will emphasize personalized medicine and tailoring treatments according to each patient's specific needs. These approaches will involve modulating the therapy intensity based on the biological characteristics of tumours and early predictive indicators, allowing for more precise and adaptable care in oncology. Additionally, there remains an unfulfilled requirement for the creation of new medications to treat breast cancer in its early stages, as well as in advanced cases. This review article presents an extensive examination of breast cancer, delving into its prevalence, contributing factors, molecular and cellular features and therapeutic interventions.

BioinformationVol. 20(12)
Lincoln University College (MY)
Good health and well-being
Openalex Percentile: Top 21%
HER2/EGFR in Cancer Research
0.85
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Breast cancer histopathology, classification and clinical management: Current perspectives — Ravindra Waykar, Srinivasakumar Kumarapillai · Bioinformation (2024) | TGRS Research Map | TGRS